LON:PYC Physiomics (PYC) Share Price, News & Analysis GBX 0.50 -0.03 (-4.76%) As of 11:42 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsBuy This Stock About Physiomics Stock (LON:PYC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Physiomics alerts:Sign Up Key Stats Today's Range 0.50▼ 0.5550-Day Range 0.43▼ 0.7252-Week Range 0.25▼ 0.80Volume3.28 million shsAverage Volume7.44 million shsMarket Capitalization£2.27 millionP/E RatioN/ADividend Yield6.20%Price TargetN/AConsensus RatingN/A Company Overview Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom. Read More Receive PYC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PYC Stock News HeadlinesPhysiomics Secures More Than £345,000 in New Drug Development Contracts (PYC)May 27, 2026 | uk.finance.yahoo.comPhysiomics Extends CEO Peter Sargent’s Contract During Strategic Transition Period (PYC)May 15, 2026 | uk.finance.yahoo.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.June 17 at 1:00 AM | Banyan Hill Publishing (Ad)Physiomics (PYC) Board Begins Strategic Review Focused on Growth and Operational EfficiencyMay 8, 2026 | uk.finance.yahoo.comISS weighs in on Physiomics ahead of general meetingApril 20, 2026 | uk.finance.yahoo.comAIM Market Roundup: Physiomics, Tern, Cleantech LithiumMarch 13, 2026 | ca.finance.yahoo.comPhysiomics shares fall 27% after discounted share placingMarch 10, 2026 | finance.yahoo.comPhysiomics secures new contract with Numab Therapeutics for antibody developmentDecember 12, 2025 | msn.comSee More Headlines PYC Stock Analysis - Frequently Asked Questions How have PYC shares performed this year? Physiomics' stock was trading at GBX 0.29 at the start of the year. Since then, PYC shares have increased by 75.4% and is now trading at GBX 0.50. How were Physiomics' earnings last quarter? Physiomics Plc (LON:PYC) issued its earnings results on Monday, February, 16th. The company reported ($0.10) earnings per share (EPS) for the quarter. Physiomics had a negative trailing twelve-month return on equity of 89.43% and a negative net margin of 50.92%. How do I buy shares of Physiomics? Shares of PYC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Physiomics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Physiomics investors own include Andalas Energy and Power (ADL), Tavistock Investments (TAVI), Parsley Box Group (MEAL), Uranium Energy (UEC), Tiziana Life Sciences (TLSA), IGas Energy (IGAS) and Hertz Global (HTZ). Company Calendar Last Earnings2/16/2026Today6/17/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PYC CIKN/A Webwww.physiomics-plc.com Phone+44-1865-784980FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£922.82 thousand Net Margins-50.92% Pretax MarginN/A Return on Equity-89.43% Return on Assets-76.38% Debt Debt-to-Equity RatioN/A Current Ratio3.30 Quick Ratio6.48 Sales & Book Value Annual Sales£953.01 thousand Price / Sales2.38 Cash FlowGBX 0.12 per share Price / Cash Flow4.21 Book ValueGBX 0.21 per share Price / Book2.40Miscellaneous Outstanding Shares453,209,000Free FloatN/AMarket Cap£2.27 million OptionableNot Optionable Beta0.95 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (LON:PYC) was last updated on 6/17/2026 by MarketBeat.com Staff. From Our PartnersIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Physiomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.